COLON CANCER
Clinical trials for COLON CANCER explained in plain language.
Never miss a new study
Get alerted when new COLON CANCER trials appear
Sign up with your email to follow new studies for COLON CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control TerminatedThis study tested a new therapy where a person's own white blood cells are collected, genetically modified in a lab to recognize a specific cancer mutation (KRAS G12D), and then given back to attack tumors. It involved 5 adults with advanced gastrointestinal, pancreatic, gastric,…
Matched conditions: COLON CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
New cancer drug trial halted early – what we know
Disease control TerminatedThis early-stage study tested a new drug called AUR106 in 21 adults with advanced cancers (lung, stomach, bladder, kidney, colon, or esophagus) that had come back or spread. The main goal was to find a safe dose and check how the drug moves through the body. The study was stopped…
Matched conditions: COLON CANCER
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
New drug PHN-010 tested in patients with advanced cancers
Disease control TerminatedThis early-phase study tested a new drug called PHN-010, which delivers a powerful toxin directly to cancer cells. It involved 26 adults with advanced lung, colon, endometrial, ovarian, or cervical cancers that had already been treated. The main goals were to check safety and fin…
Matched conditions: COLON CANCER
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
Experimental cancer pill tested in patients with advanced tumors
Disease control TerminatedThis early-phase study tested an experimental oral drug called ATX-559 in 17 people with advanced solid tumors (like breast, colon, or endometrial cancer) that had stopped responding to standard treatments. The main goal was to find a safe dose and check for side effects. The stu…
Matched conditions: COLON CANCER
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated May 19, 2026 12:00 UTC